AI Article Synopsis
- Since 2022, Europe has identified 4 cases of extensively drug-resistant Neisseria gonorrhoeae, particularly sequence type 16406, which is resistant to ceftriaxone and has high resistance to azithromycin.
- In 2023, two new related cases were reported in France that share genetic links with the previous European cases and strains from Cambodia.
- This highlights growing concerns about the spread of drug-resistant gonorrhea in Europe and its potential global implications.
Article Abstract
Since 2022, Europe has had 4 cases of extensively drug-resistant Neisseria gonorrhoeae, sequence type 16406, that is resistant to ceftriaxone and highly resistant to azithromycin. We report 2 new cases from France in 2023 involving strains genetically related to the 4 cases from Europe as well as isolates from Cambodia.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11347006 | PMC |
| http://dx.doi.org/10.3201/eid3009.240557 | DOI Listing |
Publication Analysis
Top Keywords
extensively drug-resistant
8
drug-resistant neisseria
8
neisseria gonorrhoeae
8
france 2023
8
emergence extensively
4
gonorrhoeae france
4
2023 2022
4
2022 europe
4
europe cases
4
cases extensively
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!